✦ LIBER ✦

619 THE RISK OF GLEASON SUM UPGRADING REPRESENTS AN IMPORTANT CONSIDERATION IN PATIENTS ELIGIBLE FOR LOW DOSE BRACHYTHERAPY

✍ Scribed by L. Budäus; P.I. Karakiewicz; G. Salomon; H. Isbarn; G. Lughezanni; M. Sun; K.H. Chun; T. Schlomm; T. Steuber; A. Haese; G. Sauter; M. Fisch; H. Heinzer; H. Huland; M. Graefen

Book ID: 119621345
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 78 KB
Volume: 9
Category: Article
ISSN: 1569-9056
DOI: 10.1016/s1569-9056(10)60608-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The novel nomogram of Gleason sum upgrad

The novel nomogram of Gleason sum upgrade: Possible application for the eligible criteria of low dose rate brachytherapy

✍ Lars Budäus; Markus Graefen; Georg Salomon; Hendrik Isbarn; Giovanni Lughezzani; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 549 KB

THE NUMBER OF BIOPSY CORES REPRESENTS ON

THE NUMBER OF BIOPSY CORES REPRESENTS ONE OF THE FOREMOST PREDICTOR OF CLINICALLY SIGNIFICANT GLEASON SUM UPGRADING IN LOW RISK PROSTATE CANCER PATIENTS

✍ Capitanio, Umberto; Jeldres, Claudio; Isbarn, Hendrik; Gallina, Andrea; Suardi, 📂 Article 📅 2009 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 49 KB

621 THE NUMBER OF BIOPSY CORES REPRESENT

621 THE NUMBER OF BIOPSY CORES REPRESENTS ONE OF THE FOREMOST PREDICTOR OF CLINICALLY SIGNIFICANT GLEASON SUM UPGRADING IN LOW RISK PROSTATE CANCER PATIENTS

✍ U. Capitanio; A. Briganti; A. Gallina; N. Suardi; C. Jeldres; H. Isbarn; L.F. Da 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 503 KB